BCAX (Bicara Therapeutics) Short-term investments


BCAX Bicara Therapeutics Inc BCAX
12 GF Score
Price $28.88
! 3 Warning Signs
View Full Analysis

What is Bicara Therapeutics Short-term investments?

Short-term investments only applies to insurance companies.

BCAX
12GF Score
Bicara Therapeutics Inc BCAX
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bicara Therapeutics Business Description

Address 116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.
12GF Score

Get the complete analysis for BCAX

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.88
Price